Filing Details

Accession Number:
0001209191-11-010192
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-02-16 16:44:18
Reporting Period:
2010-12-31
Filing Date:
2011-02-16
Accepted Time:
2011-02-16 16:44:18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1333170 Nxstage Medical Inc. NXTM Electromedical & Electrotherapeutic Apparatus (3845) 043454702
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1409195 J. Michael Webb C/O Nxstage Medical, Inc.
439 South Union Street
Lawrence MA 01843
Svp, Quality & Regulatory No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2010-12-31 5,522 $24.88 29,259 No 4 F Direct
Common Stock Disposition 2011-02-14 10,000 $20.85 19,259 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 F Direct
No 4 S Direct
Footnotes
  1. This transaction reflects the withholding of shares of NxStage Medical, Inc.'s common stock to satisfy the reporting person's tax liability incurred in connection with the vesting of the second tranche of awards granted to him on March 3, 2010 (the "Award") pursuant to NxStage Medical Inc.'s 2009 Performance Share Plan. The Award was reported on a previous Form 4 filed on March 5, 2010.
  2. This sale was effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on December 3, 2010.
  3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $20.68 to $21.15. The reporting person undertakes to provide to the issuer, any holder of the issuer's stock, or the SEC, upon request, full information regarding the number of shares sold at each separate price within the range described above.